These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34792325)

  • 21. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
    van Breemen RB; Muchiri RN; Bates TA; Weinstein JB; Leier HC; Farley S; Tafesse FG
    J Nat Prod; 2022 Jan; 85(1):176-184. PubMed ID: 35007072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.
    Mycroft-West CJ; Su D; Pagani I; Rudd TR; Elli S; Gandhi NS; Guimond SE; Miller GJ; Meneghetti MCZ; Nader HB; Li Y; Nunes QM; Procter P; Mancini N; Clementi M; Bisio A; Forsyth NR; Ferro V; Turnbull JE; Guerrini M; Fernig DG; Vicenzi E; Yates EA; Lima MA; Skidmore MA
    Thromb Haemost; 2020 Dec; 120(12):1700-1715. PubMed ID: 33368089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Antiviral Drug Arbidol Inhibits Zika Virus.
    Fink SL; Vojtech L; Wagoner J; Slivinski NSJ; Jackson KJ; Wang R; Khadka S; Luthra P; Basler CF; Polyak SJ
    Sci Rep; 2018 Jun; 8(1):8989. PubMed ID: 29895962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
    Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
    mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.
    Cao J; Liu Y; Zhou M; Dong S; Hou Y; Jia X; Lan X; Zhang Y; Guo J; Xiao G; Wang W
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein.
    Sun C; Zhang J; Wei J; Zheng X; Zhao X; Fang Z; Xu D; Yuan H; Liu Y
    PLoS One; 2021; 16(1):e0245975. PubMed ID: 33493227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
    Xu M; Pradhan M; Gorshkov K; Petersen JD; Shen M; Guo H; Zhu W; Klumpp-Thomas C; Michael S; Itkin M; Itkin Z; Straus MR; Zimmerberg J; Zheng W; Whittaker GR; Chen CZ
    SLAS Discov; 2022 Mar; 27(2):86-94. PubMed ID: 35086793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein.
    Yang C; Pan X; Xu X; Cheng C; Huang Y; Li L; Jiang S; Xu W; Xiao G; Liu S
    Signal Transduct Target Ther; 2020 Oct; 5(1):220. PubMed ID: 33024075
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2.
    Zhao H; To KKW; Lam H; Zhou X; Chan JF; Peng Z; Lee ACY; Cai J; Chan WM; Ip JD; Chan CC; Yeung ML; Zhang AJ; Chu AWH; Jiang S; Yuen KY
    Nat Commun; 2021 Mar; 12(1):1517. PubMed ID: 33750821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells.
    Carpinteiro A; Gripp B; Hoffmann M; Pöhlmann S; Hoertel N; Edwards MJ; Kamler M; Kornhuber J; Becker KA; Gulbins E
    J Biol Chem; 2021; 296():100701. PubMed ID: 33895135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion.
    Classen N; Pitakbut T; Schöfbänker M; Kühn J; Hrincius ER; Ludwig S; Hensel A; Kayser O
    Planta Med; 2024 Aug; 90(9):717-725. PubMed ID: 38885660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2.
    Rajasekharan S; Milan Bonotto R; Nascimento Alves L; Kazungu Y; Poggianella M; Martinez-Orellana P; Skoko N; Polez S; Marcello A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33946304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
    Prabhakara C; Godbole R; Sil P; Jahnavi S; Gulzar SE; van Zanten TS; Sheth D; Subhash N; Chandra A; Shivaraj A; Panikulam P; U I; Nuthakki VK; Puthiyapurayil TP; Ahmed R; Najar AH; Lingamallu SM; Das S; Mahajan B; Vemula P; Bharate SB; Singh PP; Vishwakarma R; Guha A; Sundaramurthy V; Mayor S
    PLoS Pathog; 2021 Jul; 17(7):e1009706. PubMed ID: 34252168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
    Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
    Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Mondal S; Karmakar A; Mallick T; Begum NA
    Virology; 2021 Apr; 556():133-139. PubMed ID: 33571798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.